Lyra Therapeutics Inc (NQ: LYRA )
0.2903
-0.0096
(-3.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 24, 2024
Add to My Watchlist
All News about Lyra Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where Lyra Therapeutics Stands With Analysts
May 07, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/wall-street-sign-buildings.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/06/Wall-Street-bull.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
What 4 Analyst Ratings Have To Say About Lyra Therapeutics
October 06, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Lyra Therapeutics: Q1 Earnings Insights
May 12, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Lyra Therapeutics's Return On Capital Employed Insights
March 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/06/Crude-oil-4-logo.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Fossil Fuels
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2024/04/djt1600.png)
Via InvestorPlace
![](https://investorplace.com/wp-content/uploads/2023/05/red-electric-vehicle-charging-ev-stocks-closeup-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_573.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2024/01/para1600.png)
![](https://investorplace.com/wp-content/uploads/2019/10/medicine.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/06/analysis-4937349.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
August 31, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5837.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/20/surgalign_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/bz-pharma_5.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/13/bz-pharma_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23161.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22567.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.